Filtros : "Indexado no CAB Abstracts" "Hirata, Rosario Dominguez Crespo" Limpar

Filtros



Refine with date range


  • Source: Pharmacogenomics. Unidade: FCF

    Subjects: FARMACOGENÉTICA, EXPRESSÃO GÊNICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WILLRICH, Maria Alice Vieira e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics, v. 10, n. 6, p. 1017-1024, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.42. Acesso em: 01 jun. 2024.
    • APA

      Willrich, M. A. V., Hirata, M. H., & Hirata, R. D. C. (2009). Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics, 10( 6), 1017-1024. doi:10.2217/pgs.09.42
    • NLM

      Willrich MAV, Hirata MH, Hirata RDC. Statin regulation of CYP3A4 and CYP3A5 expression [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1017-1024.[citado 2024 jun. 01 ] Available from: https://doi.org/10.2217/pgs.09.42
    • Vancouver

      Willrich MAV, Hirata MH, Hirata RDC. Statin regulation of CYP3A4 and CYP3A5 expression [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1017-1024.[citado 2024 jun. 01 ] Available from: https://doi.org/10.2217/pgs.09.42
  • Source: Pharmacogenomics. Unidade: FCF

    Subjects: LIPOPROTEÍNAS LDL, HIPERCOLESTEROLEMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RODRIGUES, Alice Cristina e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics, v. 10, n. 6, p. 1007-1016, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.18. Acesso em: 01 jun. 2024.
    • APA

      Rodrigues, A. C., Hirata, M. H., & Hirata, R. D. C. (2009). Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics, 10( 6), 1007-1016. doi:10.2217/pgs.09.18
    • NLM

      Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1007-1016.[citado 2024 jun. 01 ] Available from: https://doi.org/10.2217/pgs.09.18
    • Vancouver

      Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1007-1016.[citado 2024 jun. 01 ] Available from: https://doi.org/10.2217/pgs.09.18
  • Source: Genetic Testing and Molecular Biomarkers. Unidade: FCF

    Subjects: POLIMORFISMO, REAÇÃO EM CADEIA POR POLIMERASE

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA NETO, Lidio Gonçalves et al. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genetic Testing and Molecular Biomarkers, v. 13, n. 3, p. 343-347, 2009Tradução . . Disponível em: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147. Acesso em: 01 jun. 2024.
    • APA

      Lima Neto, L. G., Hirata, R. D. C., Luchessi, A. D., Silbiger, V. N., Pastorelli, C. P., Sampaio, M. F., et al. (2009). Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genetic Testing and Molecular Biomarkers, 13( 3), 343-347. Recuperado de http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
    • NLM

      Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Pastorelli CP, Sampaio MF, Armaganijan D, Rezende AA de, Doi S de Q, Hirata MH. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays [Internet]. Genetic Testing and Molecular Biomarkers. 2009 ; 13( 3): 343-347.[citado 2024 jun. 01 ] Available from: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
    • Vancouver

      Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Pastorelli CP, Sampaio MF, Armaganijan D, Rezende AA de, Doi S de Q, Hirata MH. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays [Internet]. Genetic Testing and Molecular Biomarkers. 2009 ; 13( 3): 343-347.[citado 2024 jun. 01 ] Available from: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
  • Source: Pharmacogenomics. Unidade: FCF

    Subjects: EXPRESSÃO GÊNICA, LIPOPROTEÍNAS LDL

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GENVIGIR, Fabiana Dalla Vecchia e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics, v. 10, n. 6, p. 997-1005, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.30. Acesso em: 01 jun. 2024.
    • APA

      Genvigir, F. D. V., Hirata, M. H., & Hirata, R. D. C. (2009). ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics, 10( 6), 997-1005. doi:10.2217/pgs.09.30
    • NLM

      Genvigir FDV, Hirata MH, Hirata RDC. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells [Internet]. Pharmacogenomics. 2009 ; 10( 6): 997-1005.[citado 2024 jun. 01 ] Available from: https://doi.org/10.2217/pgs.09.30
    • Vancouver

      Genvigir FDV, Hirata MH, Hirata RDC. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells [Internet]. Pharmacogenomics. 2009 ; 10( 6): 997-1005.[citado 2024 jun. 01 ] Available from: https://doi.org/10.2217/pgs.09.30
  • Source: European Journal of Pharmaceutical Sciences. Unidades: ICB, FCF

    Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RODRIGUES, Alice Cristina et al. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, v. 37, n. 3-4, p. 486-491, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2009.04.006. Acesso em: 01 jun. 2024.
    • APA

      Rodrigues, A. C., Curi, R., Hirata, M. H., & Hirata, R. D. C. (2009). Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, 37( 3-4), 486-491. doi:10.1016/j.ejps.2009.04.006
    • NLM

      Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006
    • Vancouver

      Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006
  • Source: European Journal of Clinical Nutrition. Unidade: FCF

    Subjects: POLIMORFISMO, GRAVIDEZ

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BARBOSA, Patrícia Roberto et al. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. European Journal of Clinical Nutrition, v. 62, n. 8, p. 1010-1021, 2008Tradução . . Disponível em: https://doi.org/10.1038/sj.ejcn.1602810. Acesso em: 01 jun. 2024.
    • APA

      Barbosa, P. R., Stabler, S. P., Machado, A. L. K. T., Braga, R. C., Hirata, R. D. C., Hirata, M. H., et al. (2008). Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. European Journal of Clinical Nutrition, 62( 8), 1010-1021. doi:10.1038/sj.ejcn.1602810
    • NLM

      Barbosa PR, Stabler SP, Machado ALKT, Braga RC, Hirata RDC, Hirata MH, Sampaio Neto LF de, Allen RH, Guerra-Shinohara EM. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women [Internet]. European Journal of Clinical Nutrition. 2008 ; 62( 8): 1010-1021.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1038/sj.ejcn.1602810
    • Vancouver

      Barbosa PR, Stabler SP, Machado ALKT, Braga RC, Hirata RDC, Hirata MH, Sampaio Neto LF de, Allen RH, Guerra-Shinohara EM. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women [Internet]. European Journal of Clinical Nutrition. 2008 ; 62( 8): 1010-1021.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1038/sj.ejcn.1602810

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024